Healthcare Global Enterprises Ltd

₹ 297 -2.69%
07 Dec - close price
About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Key Points

Presence across Oncology Value Chain
The company has presence across the oncology value chain, offering services for prevention, screening, diagnosis and treatment to rehabilitation, supportive care and palliative care.[1] It has implemented advanced precision technologies and specialized procedures across its cancer centers.[2]

  • Market Cap 4,129 Cr.
  • Current Price 297
  • High / Low 320 / 215
  • Stock P/E
  • Book Value 63.4
  • Dividend Yield 0.00 %
  • ROCE 5.36 %
  • ROE -0.81 %
  • Face Value 10.0

Pros

Cons

  • Stock is trading at 4.69 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -13.2% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
278.46 277.93 270.37 193.46 247.92 274.01 298.05 323.14 351.96 358.06 364.63 408.05 420.00
237.77 234.42 235.88 176.01 217.90 236.17 258.69 271.91 292.22 296.21 301.48 335.89 345.31
Operating Profit 40.69 43.51 34.49 17.45 30.02 37.84 39.36 51.23 59.74 61.85 63.15 72.16 74.69
OPM % 14.61% 15.66% 12.76% 9.02% 12.11% 13.81% 13.21% 15.85% 16.97% 17.27% 17.32% 17.68% 17.78%
1.52 2.46 1.69 2.72 4.45 -2.69 -79.42 4.01 143.42 -42.59 3.01 2.91 1.97
Interest 34.55 36.11 35.80 37.39 27.16 28.71 25.91 26.38 23.23 24.02 24.14 24.98 25.81
Depreciation 34.57 37.70 42.06 39.41 39.60 41.83 38.38 37.78 38.02 41.38 41.10 39.67 40.83
Profit before tax -26.91 -27.84 -41.68 -56.63 -32.29 -35.39 -104.35 -8.92 141.91 -46.14 0.92 10.42 10.02
Tax % 6.13% -4.74% -21.02% 19.46% 16.38% 1.86% -9.02% -40.36% 30.24% -7.93% -144.57% 76.20% 47.21%
Net Profit -25.26 -29.16 -50.44 -45.61 -27.00 -34.73 -113.76 -12.52 98.99 -49.80 2.25 2.48 5.29
EPS in Rs -2.51 -2.57 -4.91 -4.48 -1.78 -2.33 -8.15 -0.76 8.22 -3.29 0.43 0.44 0.53
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
215 267 338 451 519 584 700 829 976 1,092 1,009 1,395 1,551
177 225 292 413 443 499 595 713 864 936 887 1,161 1,279
Operating Profit 38 41 47 38 76 85 105 116 112 157 122 234 272
OPM % 18% 15% 14% 9% 15% 15% 15% 14% 11% 14% 12% 17% 18%
1 4 2 3 0 -2 10 25 10 10 -72 110 -35
Interest 14 24 29 32 34 38 23 42 70 138 119 98 99
Depreciation 18 24 30 36 39 44 57 71 85 148 159 158 163
Profit before tax 8 -3 -10 -27 3 0 35 27 -33 -119 -229 88 -25
Tax % 12% -8% -7% -20% -56% -730% 34% 38% 7% -5% 3% 56%
Net Profit 7 -3 -11 -32 5 2 23 17 -31 -125 -221 39 -40
EPS in Rs 1.18 -0.56 -1.54 -5.21 0.12 -0.17 2.59 2.36 -2.82 -12.03 -15.43 3.87 -1.89
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 18%
5 Years: 15%
3 Years: 13%
TTM: 24%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 20%
TTM: 99%
Stock Price CAGR
10 Years: %
5 Years: 1%
3 Years: 45%
1 Year: 16%
Return on Equity
10 Years: -6%
5 Years: -9%
3 Years: -13%
Last Year: -1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
53 59 67 68 70 85 86 87 88 89 125 139 139
Reserves 110 152 216 195 209 341 347 398 389 293 528 731 742
134 217 308 292 349 324 420 464 658 1,347 977 915 900
64 77 117 133 148 294 372 491 515 518 401 433 491
Total Liabilities 361 505 708 688 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,272
267 392 508 512 528 583 685 828 970 1,646 1,382 1,547 1,503
CWIP 0 0 0 11 42 121 148 174 153 46 30 22 64
Investments 1 0 61 2 0 64 11 53 49 34 26 9 9
93 112 139 164 205 275 381 385 478 520 593 641 697
Total Assets 361 505 708 688 776 1,043 1,225 1,440 1,650 2,246 2,031 2,218 2,272

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
36 19 31 51 60 73 91 98 98 130 121 220
-34 -46 -178 -12 -79 -204 -210 -283 -238 -101 -171 125
-1 38 140 -27 22 216 89 161 84 -58 112 -155
Net Cash Flow 1 11 -7 13 2 85 -29 -24 -56 -30 62 190

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 50 59 65 43 45 43 54 57 59 62 67 57
Inventory Days 32 32 35 33 36 32 40 46 45 35 32 31
Days Payable 214 163 186 193 208 264 272 274 303 234 221 199
Cash Conversion Cycle -133 -73 -86 -117 -127 -188 -178 -171 -200 -136 -121 -112
Working Capital Days -7 16 -4 -20 -44 -72 -90 -73 -92 -70 33 -21
ROCE % 6% 4% 1% 7% 7% 7% 7% 4% 1% -1% 5%

Shareholding Pattern

Numbers in percentages

1 recently
Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
23.90 23.90 23.90 66.91 66.87 70.71 68.41 68.40 71.44 71.43 71.42 71.39
27.58 25.05 22.49 7.08 6.77 6.34 6.42 7.24 7.03 6.99 7.22 7.27
29.64 29.65 26.13 11.54 12.88 9.62 9.69 8.16 6.59 5.86 4.55 4.02
18.87 21.40 27.48 14.47 13.48 13.33 15.48 16.19 14.94 15.73 16.81 17.32

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents

Concalls